IL-17

    RT @MeralElRamahiMD: #EULAR2021 bDMARD and TNF-i naive patients w/ r-axSpA without evidence of objective inflammation (n

    Meral K. El Ramahi, MD MeralElRamahiMD

    2 years 11 months ago
    #EULAR2021 bDMARD and TNF-i naive patients w/ r-axSpA without evidence of objective inflammation (normal CRP & MRI ) showed ASA40 response w/ ixekizumab @RheumNow https://t.co/5KT8A81auq
    New download available!

    Difficult RA Defined

    https://t.co/6WGMEiwiUk https://t.co/VTCm4cuyRe

    Dr. John Cush RheumNow

    2 years 11 months ago
    New download available! Difficult RA Defined https://t.co/6WGMEiwiUk https://t.co/VTCm4cuyRe

    Podcasts

    • Don't You Know Who I Am (5.17.2024)
    • My Cancelled Lecture (5.11.2024)
    • Roadblocks to reaching remission in lupus Sponsored by GSK US Medical Affairs

    Catch up on Conference Podcasts

    Featured Video

    Do you get our email newsletter?

    Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

    Copyright {{ 'now'|date('Y') }} All Rights Reserved.